🇺🇸 FDA
Pipeline program

DCVac-L

UPCC 11807

Phase 1 mab completed

Quick answer

DCVac-L for Ovarian Cancer is a Phase 1 program (mab) at NORTHWEST BIOTHERAPEUTICS INC with 1 ClinicalTrials.gov record(s).

Program details

Company
NORTHWEST BIOTHERAPEUTICS INC
Indication
Ovarian Cancer
Phase
Phase 1
Modality
mab
Status
completed

Clinical trials